In another study, investigators showed that miR‐139‐5p increased cisplatin sensitivity in NSCLC cells by suppressing cell development and increasing programmed cell death by regulating Homeobox protein Hox‐B2 (HOXB2) [246]. This evidence concerns the gene HOXB2 and non-small cell lung carcinoma.